Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)



Banach, Maciej, Penson, Peter E ORCID: 0000-0001-6763-1489, Vrablik, Michal, Bunc, Matjaz, Dyrbus, Krzysztof, Fedacko, Jan, Gaita, Dan, Gierlotka, Marek, Jarai, Zoltan, Magda, Stefania Lucia
et al (show 13 more authors) (2021) Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). PHARMACOLOGICAL RESEARCH, 166.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: Combination therapy, Effectiveness, Ezetimibe, PCSK9 inhibitors, Safety, Statins
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 30 Jun 2021 13:05
Last Modified: 20 Oct 2021 20:22
DOI: 10.1016/j.phrs.2021.105499
Open Access URL: https://www.sciencedirect.com/science/article/pii/...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3128271